047920 Stock Chart & Stats
₩8150.00
₩220.00(2.77%)
―
--
Day’s Range― - ―
52-Week Range₩6,000.00 - ₩22,250.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)268.32K
Market Cap
₩260.09B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)71.6
Beta0.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding32,799,355
10 Day Avg. Volume575,212
30 Day Avg. Volume268,325
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
047920 FAQ
What was HLB PHARMACEUTICAL CO., LTD.’s price range in the past 12 months?
HLB PHARMACEUTICAL CO., LTD. lowest stock price was ₩6000.00 and its highest was ₩22250.00 in the past 12 months.
What is HLB PHARMACEUTICAL CO., LTD.’s market cap?
HLB PHARMACEUTICAL CO., LTD.’s market cap is ₩260.09B.
When is HLB PHARMACEUTICAL CO., LTD.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HLB PHARMACEUTICAL CO., LTD.’s earnings last quarter?
HLB PHARMACEUTICAL CO., LTD. released its earnings results on May 13, 2026. The company reported ₩21.955 earnings per share for the quarter, beating the consensus estimate of N/A by ₩21.955.
Is HLB PHARMACEUTICAL CO., LTD. overvalued?
According to Wall Street analysts HLB PHARMACEUTICAL CO., LTD.’s price is currently Undervalued.
Does HLB PHARMACEUTICAL CO., LTD. pay dividends?
HLB PHARMACEUTICAL CO., LTD. does not currently pay dividends.
What is HLB PHARMACEUTICAL CO., LTD.’s EPS estimate?
HLB PHARMACEUTICAL CO., LTD.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HLB PHARMACEUTICAL CO., LTD. have?
HLB PHARMACEUTICAL CO., LTD. has 32,799,355 shares outstanding.
What happened to HLB PHARMACEUTICAL CO., LTD.’s price movement after its last earnings report?
HLB PHARMACEUTICAL CO., LTD. reported an EPS of ₩21.955 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.296%.
Which hedge fund is a major shareholder of HLB PHARMACEUTICAL CO., LTD.?
Currently, no hedge funds are holding shares in KR:047920
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kwang Dong Pharmaceutical Co., Ltd.
―
Hans Biomed Corp
―
Dong-A ST Co., Ltd.
―
HUONS CO., LTD
―
Hem Pharma, Inc.
―